<VariationArchive VariationID="371091" VariationName="NM_001079802.2(FKTN):c.1106del (p.Phe369fs)" VariationType="Deletion" Accession="VCV000371091" Version="16" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-17" DateCreated="2017-01-06" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357769" VariationID="371091">
      <GeneList>
        <Gene Symbol="FKTN" FullName="fukutin" GeneID="2218" HGNC_ID="HGNC:3622" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="105558130" stop="105641118" display_start="105558130" display_stop="105641118" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="108320410" stop="108403398" display_start="108320410" display_stop="108403398" Strand="+" />
          </Location>
          <OMIM>607440</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001079802.2(FKTN):c.1106del (p.Phe369fs)</Name>
      <CanonicalSPDI>NC_000009.12:105619988:TTTTTTT:TTTTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="105619989" stop="105619989" display_start="105619989" display_stop="105619989" variantLength="1" positionVCF="105619988" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="108382270" stop="108382270" display_start="108382270" display_stop="108382270" variantLength="1" positionVCF="108382269" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F237fs</ProteinChange>
      <ProteinChange>F369fs</ProteinChange>
      <ProteinChange>F346fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079802.1" sequenceAccession="NM_001079802" sequenceVersion="1" change="c.1106delT">
            <Expression>NM_001079802.1:c.1106delT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.108382276del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.108382276del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.105619995del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.105619995del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008754.1" sequenceAccession="NG_008754" sequenceVersion="1" change="g.66866del">
            <Expression>NG_008754.1:g.66866del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079802.2" sequenceAccession="NM_001079802" sequenceVersion="2" change="c.1106del" MANESelect="true">
            <Expression>NM_001079802.2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073270.1" sequenceAccession="NP_001073270" sequenceVersion="1" change="p.Phe369fs">
            <Expression>NP_001073270.1:p.Phe369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001198963.2" sequenceAccession="NM_001198963" sequenceVersion="2" change="c.1106del">
            <Expression>NM_001198963.2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001185892.1" sequenceAccession="NP_001185892" sequenceVersion="1" change="p.Phe369fs">
            <Expression>NP_001185892.1:p.Phe369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351496.2" sequenceAccession="NM_001351496" sequenceVersion="2" change="c.1106del">
            <Expression>NM_001351496.2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338425.1" sequenceAccession="NP_001338425" sequenceVersion="1" change="p.Phe369fs">
            <Expression>NP_001338425.1:p.Phe369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351497.2" sequenceAccession="NM_001351497" sequenceVersion="2" change="c.1037del">
            <Expression>NM_001351497.2:c.1037del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338426.1" sequenceAccession="NP_001338426" sequenceVersion="1" change="p.Phe346fs">
            <Expression>NP_001338426.1:p.Phe346fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351498.2" sequenceAccession="NM_001351498" sequenceVersion="2" change="c.1106del">
            <Expression>NM_001351498.2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338427.1" sequenceAccession="NP_001338427" sequenceVersion="1" change="p.Phe369fs">
            <Expression>NP_001338427.1:p.Phe369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351499.2" sequenceAccession="NM_001351499" sequenceVersion="2" change="c.710del">
            <Expression>NM_001351499.2:c.710del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338428.1" sequenceAccession="NP_001338428" sequenceVersion="1" change="p.Phe237fs">
            <Expression>NP_001338428.1:p.Phe237fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351500.2" sequenceAccession="NM_001351500" sequenceVersion="2" change="c.710del">
            <Expression>NM_001351500.2:c.710del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338429.1" sequenceAccession="NP_001338429" sequenceVersion="1" change="p.Phe237fs">
            <Expression>NP_001338429.1:p.Phe237fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351501.2" sequenceAccession="NM_001351501" sequenceVersion="2" change="c.710del">
            <Expression>NM_001351501.2:c.710del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338430.1" sequenceAccession="NP_001338430" sequenceVersion="1" change="p.Phe237fs">
            <Expression>NP_001338430.1:p.Phe237fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351502.2" sequenceAccession="NM_001351502" sequenceVersion="2" change="c.710del">
            <Expression>NM_001351502.2:c.710del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001338431.1" sequenceAccession="NP_001338431" sequenceVersion="1" change="p.Phe237fs">
            <Expression>NP_001338431.1:p.Phe237fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006731.2" sequenceAccession="NM_006731" sequenceVersion="2" change="c.1106del">
            <Expression>NM_006731.2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006722.2" sequenceAccession="NP_006722" sequenceVersion="2" change="p.Phe369fs">
            <Expression>NP_006722.2:p.Phe369fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147213.2" sequenceAccession="NR_147213" sequenceVersion="2" change="n.1057del">
            <Expression>NR_147213.2:n.1057del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_147214.2" sequenceAccession="NR_147214" sequenceVersion="2" change="n.1229del">
            <Expression>NR_147214.2:n.1229del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_434" sequenceAccession="LRG_434">
            <Expression>LRG_434:g.66866del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_434t2" sequenceAccession="LRG_434t2">
            <Expression>LRG_434t2:c.1106del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_434p2" sequenceAccession="LRG_434p2" change="p.Phe369fs">
            <Expression>LRG_434p2:p.Phe369fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_434t1" sequenceAccession="LRG_434t1">
            <Expression>LRG_434t1:c.1106del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079802.1" sequenceAccession="NM_001079802" sequenceVersion="1" change="c.1100delT">
            <Expression>NM_001079802.1:c.1100delT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006731.2" sequenceAccession="NM_006731" sequenceVersion="2" change="c.1106delT">
            <Expression>NM_006731.2:c.1106delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA5170569" DB="ClinGen" />
        <XRef Type="rs" ID="750176716" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1106del (p.Phe369fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" Accession="RCV000411430" Version="6">
        <ClassifiedConditionList TraitSetID="6475">
          <ClassifiedCondition DB="MedGen" ID="C0410174">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-07" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1106del (p.Phe369fs) AND Walker-Warburg congenital muscular dystrophy" Accession="RCV000801939" Version="6">
        <ClassifiedConditionList TraitSetID="31131">
          <ClassifiedCondition DB="MedGen" ID="C0265221">Walker-Warburg congenital muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1106del (p.Phe369fs) AND Dilated cardiomyopathy 1X" Accession="RCV003470343" Version="2">
        <ClassifiedConditionList TraitSetID="821">
          <ClassifiedCondition DB="MedGen" ID="C1969024">Dilated cardiomyopathy 1X</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001079802.2(FKTN):c.1106del (p.Phe369fs) AND Cardiovascular phenotype" Accession="RCV003298418" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-27" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2017-01-06" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17878207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18177472</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18752264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19266496</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27065010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31742715</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32721234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33200426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35587316</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35843586</ID>
        </Citation>
        <DescriptionHistory Dated="2019-08-13">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31131" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="35635" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy-dystroglycanopathy, type A</ElementValue>
                <XRef ID="MONDO:0000171" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg syndrome</ElementValue>
                <XRef ID="899" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Walker-Warburg congenital muscular dystrophy</ElementValue>
                <XRef ID="Walker-Warburg+syndrome/7436" DB="Genetic Alliance" />
                <XRef ID="111504002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2599" />
                <XRef ID="2599" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0265221" DB="MedGen" />
              <XRef ID="MONDO:0000171" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS236670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="821" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="717" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">FKTN-Related Dilated Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, DILATED, WITH MILD OR NO PROXIMAL MUSCLE WEAKNESS</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dilated cardiomyopathy 1X</ElementValue>
                <XRef ID="MONDO:0012704" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMD1X</ElementValue>
                <XRef Type="MIM" ID="611615" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15522" />
                <XRef ID="15522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <XRef ID="154" DB="Orphanet" />
              <XRef ID="C1969024" DB="MedGen" />
              <XRef ID="MONDO:0012704" DB="MONDO" />
              <XRef Type="MIM" ID="611615" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6475" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1903" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4</ElementValue>
                <XRef ID="MONDO:0009678" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Walker-Warburg Syndrome, Fktn-Related</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama type muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fukuyama congenital muscular dystrophy</ElementValue>
                <XRef ID="Fukuyama+Type+Muscular+Dystrophy/2962" DB="Genetic Alliance" />
                <XRef ID="111502003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital progressive, with mental retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, congenital, with central nervous system involvement</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebromuscular dystrophy, Fukuyama type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKTN-RELATED</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MDDGA4</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FCMD</ElementValue>
                <XRef Type="MIM" ID="253800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fukuyama congenital muscular dystrophy (FCMD) is characterized by hypotonia, symmetric generalized muscle weakness, and CNS migration disturbances that result in changes consistent with cobblestone lissencephaly with cerebral and cerebellar cortical dysplasia. Mild, typical, and severe phenotypes are recognized. Onset typically occurs in early infancy with poor suck, weak cry, and floppiness. Affected individuals have contractures of the hips, knees, and interphalangeal joints. Later features include myopathic facial appearance, pseudohypertrophy of the calves and forearms, motor and speech delays, intellectual disability, seizures, ophthalmologic abnormalities including visual impairment and retinal dysplasia, and progressive cardiac involvement after age ten years. Swallowing disturbance occurs in individuals with severe FCMD and in individuals older than age ten years, leading to recurrent aspiration pneumonia and death.</Attribute>
                <XRef ID="NBK1206" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6475" />
                <XRef ID="6475" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301385</ID>
                <ID Source="BookShelf">NBK1206</ID>
              </Citation>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <XRef ID="272" DB="Orphanet" />
              <XRef ID="588" DB="Orphanet" />
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C0410174" DB="MedGen" />
              <XRef ID="MONDO:0009678" DB="MONDO" />
              <XRef Type="MIM" ID="253800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1807797" SubmissionDate="2019-05-18" DateLastUpdated="2019-06-23" DateCreated="2019-06-23">
        <ClinVarSubmissionID localKey="chr9:108382270_108382270delT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000924454" DateUpdated="2019-06-23" DateCreated="2019-06-23" Type="SCV" Version="1" SubmitterName="Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS" OrgID="505641" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>India</GeographicOrigin>
              <Tissue>fetus sample after autopsy</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>Illumina HiSeq2501</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <Software name="BWA version 0.7.12" purpose="Alignment; Variant calling; Variant Annotation" version="GATK version 3.5; Annovar version 4" />
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole exome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1100delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>Frameshift variant</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB5638272</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="950316" SubmissionDate="2019-08-05" DateLastUpdated="2019-06-23" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="907199|OMIM:253800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000486566" DateUpdated="2019-06-23" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="G" referenceAllele="GT" start="108382269" stop="108382270" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1365067" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-04" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="NM_006731.2:c.1106delT|MedGen:C0410174" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000698715" DateUpdated="2023-10-04" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33200426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32721234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31742715</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35843586</ID>
          </Citation>
          <Comment>Variant summary: FKTN c.1106delT (p.Phe369SerfsX37) results in a premature termination codon and is predicted to cause truncation of the encoded protein, which is a commonly known mechanism for disease. Although the variant is not predicted to cause absence of the protein through nonsense mediated decay, the variant is predicted to disrupt the last 93 amino acids in the protein sequence. Variants downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 251154 control chromosomes (gnomAD). c.1106delT has been reported in the literature in individuals affected with Walker-Warburg Syndrome (e.g. Aggarwal_2020, Tan_2020, Song_2021, Li_2022). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31742715, 35843586, 33200426, 32721234). Four ClinVar submitters have assessed the variant since 2014: two classified the variant as likely pathogenic, and two as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006731.2:c.1106delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0410174" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
          <SubmissionName>SUB13878306</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1835692" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2335913|MedGen:C0265221" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000941744" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17878207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18177472</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19266496</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27065010</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe369Serfs*37) in the FKTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 93 amino acid(s) of the FKTN protein. This variant is present in population databases (rs750176716, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FKTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 371091). This variant disrupts a region of the FKTN protein in which other variant(s) (p.Phe390Ilefs*14) have been determined to be pathogenic (PMID: 17878207, 18177472, 18752264, 19266496, 27065010). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.108382270del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265221" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7412183" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-07-08">
        <ClinVarSubmissionID localKey="a863501|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003993409" DateUpdated="2024-05-01" DateCreated="2023-07-08" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31742715</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33200426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35587316</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35843586</ID>
          </Citation>
          <Comment>The c.1106delT pathogenic mutation, located in coding exon 8 of the FKTN gene, results from a deletion of one nucleotide at nucleotide position 1106, causing a translational frameshift with a predicted alternate stop codon (p.F369Sfs*37). This alteration occurs at the 3' terminus of theFKTN gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 93 amino acids (20%) of the protein. However, premature stop codons are typically deleterious in nature, a significant portion of the protein is affected, and the impacted region is critical for protein function (Ambry internal data). This variant has been reported in the homozygous and compound heterozygous states with other FKTN variants in individuals reported to have features of dystroglycanopathies (Aggarwal S et al. Prenat Diagn, 2020 Jan;40:260-273; Song D et al. Clin Genet, 2021 Mar;99:384-395). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKTN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.1:c.1106delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough061523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7849988" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001079802.2:c.1106del|OMIM:611615" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004197457" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001079802.2:c.1106del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="611615" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7412183" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="950316" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1835692" TraitType="Disease" MappingType="XRef" MappingValue="C0265221" MappingRef="MedGen">
        <MedGen CUI="C0265221" Name="Walker-Warburg congenital muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1807797" TraitType="Disease" MappingType="XRef" MappingValue="253800" MappingRef="OMIM">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1365067" TraitType="Disease" MappingType="XRef" MappingValue="C0410174" MappingRef="MedGen">
        <MedGen CUI="C0410174" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7849988" TraitType="Disease" MappingType="XRef" MappingValue="611615" MappingRef="OMIM">
        <MedGen CUI="C1969024" Name="Dilated cardiomyopathy 1X" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

